Wells Fargo & Company MN Buys 9,403 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Wells Fargo & Company MN increased its stake in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 53.7% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 26,915 shares of the company’s stock after acquiring an additional 9,403 shares during the period. Wells Fargo & Company MN’s holdings in Stereotaxis were worth $61,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Jane Street Group LLC increased its position in Stereotaxis by 26.9% during the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after buying an additional 6,313 shares during the last quarter. Barclays PLC increased its position in Stereotaxis by 449.9% during the third quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after buying an additional 83,412 shares during the last quarter. SG Americas Securities LLC increased its position in Stereotaxis by 39.2% during the fourth quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock worth $60,000 after buying an additional 7,417 shares during the last quarter. Traynor Capital Management Inc. acquired a new position in Stereotaxis during the fourth quarter worth approximately $366,000. Finally, Wealth Effects LLC increased its position in Stereotaxis by 11.7% during the fourth quarter. Wealth Effects LLC now owns 86,060 shares of the company’s stock worth $196,000 after buying an additional 9,000 shares during the last quarter. Institutional investors own 45.35% of the company’s stock.

Insider Transactions at Stereotaxis

In other news, Director Paul J. Isaac bought 38,000 shares of the stock in a transaction dated Monday, March 10th. The shares were bought at an average price of $1.81 per share, for a total transaction of $68,780.00. Following the completion of the purchase, the director now owns 87,299 shares in the company, valued at approximately $158,011.19. This trade represents a 77.08% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 18.52% of the stock is owned by corporate insiders.

Stereotaxis Stock Up 1.9%

Shares of NYSEAMERICAN STXS opened at $2.11 on Wednesday. The business’s 50 day moving average price is $1.88 and its two-hundred day moving average price is $2.07. The company has a market cap of $178.78 million, a PE ratio of -7.54 and a beta of 1.54. Stereotaxis, Inc. has a twelve month low of $1.54 and a twelve month high of $2.72.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.